Ramona M. Lloyd
General Counsel bei OPTINOSE, INC.
Profil
Ramona M.
Lloyd is a regulatory affairs and quality professional.
She is currently the Vice President of Regulatory Affairs & Quality at OptiNose, Inc. Her former positions include Director of Regulatory Affairs & Quality at Sanofi SA, Vice President of Regulatory Affairs at Bristol Myers Squibb Co., Vice President of Regulatory Affairs at Johnson & Johnson, Senior Vice President of Regulatory Affairs & Safety at ImClone LLC, and Vice President of Regulatory Affairs at Omthera Pharmaceuticals, Inc. She received her undergraduate degree from the University of Massachusetts and her doctorate from Robert Wood Johnson Medical School.
Aktive Positionen von Ramona M. Lloyd
Unternehmen | Position | Beginn |
---|---|---|
OPTINOSE, INC. | General Counsel | 12.06.2014 |
Ehemalige bekannte Positionen von Ramona M. Lloyd
Unternehmen | Position | Ende |
---|---|---|
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | General Counsel | 01.01.2012 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | General Counsel | 01.01.2010 |
Sanofi SA | General Counsel | - |
JOHNSON & JOHNSON | General Counsel | - |
BRISTOL-MYERS SQUIBB COMPANY | General Counsel | - |
Ausbildung von Ramona M. Lloyd
University of Massachusetts | Undergraduate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OPTINOSE, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 3 |
---|---|
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Sanofi SA | Health Technology |